Fred Hutchinson Cancer Research Center’s latest findings will be featured in about 50 presentations at the annual meeting of the American Association for Cancer Research, “Driving Innovative Cancer Science to Patient Care,” to be held April 14-18 in Chicago.
This year’s AACR annual meeting puts a spotlight on Hutch researchers working on next-gen approaches to transgenic T-cell receptor, or TCR, immunotherapy, in which patients’ T cells are genetically engineered to produce a naturally occurring, cancer-targeting receptor called a TCR.
Presentation topics include:
For more information or to arrange an interview, please contact Molly McElroy at 206.667.6651 or email our media relations team.